CS18: a new drug that can potentially overcome cancer drug resistance
CS18 is a candidate for further development as a drug that could become part of combination treatments to prevent or overcome cancer drug resistance.

CS18 is a candidate for further development as a drug that could become part of combination treatments to prevent or overcome cancer drug resistance.
Read about health news, medical education, community updates, and events around the College.
Isabel Valdez explains what parents need to know about their child’s physical checkups ahead of the school year.
Stories from the Center for Medical Ethics and Health Policy.
One of the most rewarding parts of my career has been seeing how meaningful change can begin with something as simple as bringing people together.
Read more about research at Baylor College of Medicine.
A new computational method enables scientists to more accurately identify genetic changes linked to disease.
Read The Stitch, the official blog of the Michael E. DeBakey Department of Surgery.
Learn more about Dr. David Holmes’ seventh and final year of the Global Surgery Residency Track at Baylor College of Medicine.